Transaction · 0000950170-24-001197

LEONARD JOHN M

LEONARD JOHN M, PRES, reported a transaction classified as exercise at Intellia Therapeutics, Inc. involving 7848.000000 shares. Reported holdings after the transaction were 865709.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

exerciseSEC transaction code MPRES
NTLAIntellia Therapeutics, Inc.
Filing timeJan 03
Trade dateJan 01, 2024
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

NTLA price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
NTLA since 2024-01-03Filed 975 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0000950170-24-001197
Common Stock
Transaction date
Jan 01, 2024
Filed Jan 03, 2024, 05:30 PM · 2d delay
Shares
7.84k sh
Price unknown
Estimated value
—
Computed from shares × price
Holdings after
865k sh
Direct

Filing warnings

Notes recorded with this filing
1 warning
missing priceThe filing did not provide a usable price per share.

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership
+2score
Filing-only score

+2

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

President and CEO

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.

  2. F2

    Shares held by the John M. Leonard 2015 Irrevocable Trust.

  3. F3

    On March 3, 2021, the reporting person was granted 31,394 RSUs pursuant to the Intellia Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan. Each RSU represents a contingent…

Original filing · 0000950170-24-001197
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

NTLA